Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 3/20 | 0.57 |
| ▸ | CNR2 | P34972 | 3/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.55 |
| ▸ | HTR1B | P28222 | 4/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.53 |
| ▸ | HTR2B | P41595 | 1/20 | 0.53 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.53 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.53 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.53 |
| ▸ | HTR1D | P28221 | 1/20 | 0.51 |
| ▸ | THRA | P10827 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6938193 | 1.00 | CNR1 (0.57) | CNR1CNR2CYP2C9HTR1BMEN1 | |
| SCHEMBL2917038 | 1.00 | CNR1 (0.57) | CNR1CNR2CYP2C9HTR1BMEN1 | |
| SCHEMBL29802338 | 0.92 | CNR1 (0.61) | CNR1CNR2CYP2C9HTR1BMEN1 | |
| SCHEMBL30630917 | 0.92 | CNR1 (0.61) | CNR1CNR2CYP2C9HTR1BMEN1 | |
| SCHEMBL29802558 | 0.92 | CNR1 (0.61) | CNR1CNR2CYP2C9HTR1BMEN1 | |
| SCHEMBL23271677 | 0.92 | CNR1 (0.61) | CNR1CNR2CYP2C9HTR1BMEN1 | |
| SCHEMBL29802382 | 0.92 | CNR1 (0.61) | CNR1CNR2CYP2C9HTR1BMEN1 | |
| SCHEMBL23271675 | 0.92 | CNR1 (0.61) | CNR1CNR2CYP2C9HTR1BMEN1 | |
| SCHEMBL19612290 | 0.92 | CNR1 (0.61) | CNR1CNR2CYP2C9HTR1BMEN1 | |
| SCHEMBL2924471 | 0.91 | CYP2C9 (0.59) | CNR1CNR2CYP2C9HTR1BMCHR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9343198-B2 | Polyolefin composition for medium/high/extra high voltage cables with improved electrical breakdown strength | BOREALIS TECHNOLOGY OY (FI) | 2016-05-17 | — | — | US | disclosed |
| US-20130341066-A1 | Polyolefin Composition for Medium/High/Extra High Voltage Cables with Improved Electrical Breakdown Strength | BOREALIS TECHNOLOGY OY (FI) | 2013-12-26 | — | — | US | disclosed |
| US-8519037-B2 | Polyolefin composition for medium/high/extra high voltage cables with improved electrical breakdown strength | BOREALIS TECHNOLOGY OY (FI) | 2013-08-27 | — | — | US | disclosed |
| US-20120016147-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND POLYMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-01-19 | — | — | US | disclosed |
| US-8048982-B2 | Method for producing aromatic compound polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-11-01 | — | — | US | disclosed |
| US-20100263903-A1 | Polyolefin Composition for Medium/High/Extra High Voltage Cables with Improved Electrical Breakdown Strength | BOREALIS TECHNOLOGY OY (FI) | 2010-10-21 | — | — | US | disclosed |
| EP-2241547-A1 | Method for producing aromatic compound polymer | Sumitomo Chemical Company, Limited (JP) | 2010-10-20 | — | — | EP | disclosed |
| EP-2241548-A1 | Vanadium di-nuclear complex | Sumitomo Chemical Company, Limited (JP) | 2010-10-20 | — | — | EP | disclosed |
| EP-2072569-B1 | Polyolefin composition for medium/high/extra high voltage cables with improved electrical breakdown strength | BOREALIS TECH OY (FI) | 2010-09-01 | — | — | EP | disclosed |
| WO-2009080307-A1 | POLYOLEFIN COMPOSITION FOR MEDIUM/HIGH/EXTRA HIGH VOLTAGE CABLES WITH IMPROVED ELECTRICAL BREAKDOWN STRENGTH | BOREALIS TECHNOLOGY OY (FI) | 2009-07-02 | — | — | WO | disclosed |
| EP-2072569-A1 | Polyolefin composition for medium/high/extra high voltage cables with improved electrical breakdown strength | Borealis Technology OY (FI) | 2009-06-24 | — | — | EP | disclosed |
| US-20090018309-A1 | Method for Producing Aromatic Compound Polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-01-15 | — | — | US | disclosed |
| EP-1767560-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND POLYMER | Sumitomo Chemical Company, Limited (JP) | 2007-03-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090018309-A1 | Method for Producing Aromatic Compound Polymer | PAH, MAOA, AHR | CNR1 4580/4885CNR2 3717/4885CYP2C9 166/4885 |
| US-20120016147-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND POLYMER | PAH, MAOA, AHR | CNR1 4601/4885CNR2 3748/4885CYP2C9 159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.